Thyroid Manager requires free registration
Login or Register

Recent Posts

Relation of Stimulated Post Ablation Tg to Tumor Recurrence

Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. Kloos RT J Clin Endocrinol Metab. 2010 Dec;95(12):5241-8. Epub One hundred seven patients had initial thyroid cancer surgery and subsequent remnant radioiodine ablation. Patients underwent recombinant human TSH (rhTSH)-mediated diagnostic whole-body scan and rhTSH-stimulated thyroglobulin (Tg) measurement before […]

Read more »

An Extensive Review of the Role of Selenium in Thyroid Homeostasis

Selenium and the thyroid: a close-knit connection. Duntas LH J Clin Endocrinol Metab. 2010 Dec;95(12):5180-8. Epub 2010 Sep 1. The recent recognition that the essential trace element selenium is incorporated as selenocysteine in all three deiodinases has decisively confirmed the clear-cut link between selenium and thyroid function. It has additionally been established that the thyroid […]

Read more »

Making the Case for RAI Treatment of Intra-thoracic Goiter

Approach to management of the patient with primary or secondary intrathoracic goiter. Hegedüs L , Bonnema SJ J Clin Endocrinol Metab. 2010 Dec;95(12):5155-62. Intrathoracic (substernal) goiter, depending on definition, is seen in up to 45% of all patients operated for goiter. It can either be primary (ectopic thyroid tissue detached from a cervical thyroid mass), […]

Read more »

Correlation of BRAF V600E mutations and tumor invaseness in papillary thyroid carcinoma

JCEM 2010, 95(9):4197-4205 Basolo et al Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule remains a unique parameter that can be evaluated by histopathological examination to label a papillary thyroid carcinoma (PTC) of 20 mm or less in size as a pT1 or pT3 tumor. We correlated the BRAF V600E mutation with […]

Read more »

High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel

J Clin Endocrinol Metab. 2010 Sep;95(9):E54-7. Epub 2010 Jun 30. Troch M , Koperek O , Scheuba C , Dieckmann K , Hoffmann M , Niederle B , Raderer M Anaplastic thyroid carcinoma (ATC) is a rare but aggressive solid tumor with a very short survival time even with multimodality treatment. In view of in […]

Read more »

Recent Posts

Relation of Stimulated Post Ablation Tg to Tumor Recurrence

Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. Kloos RT J Clin Endocrinol Metab. 2010 Dec;95(12):5241-8. Epub One hundred seven patients had initial thyroid cancer surgery and subsequent remnant radioiodine ablation. Patients underwent recombinant human TSH (rhTSH)-mediated diagnostic whole-body scan and rhTSH-stimulated thyroglobulin (Tg) measurement before […]

Read more »

An Extensive Review of the Role of Selenium in Thyroid Homeostasis

Selenium and the thyroid: a close-knit connection. Duntas LH J Clin Endocrinol Metab. 2010 Dec;95(12):5180-8. Epub 2010 Sep 1. The recent recognition that the essential trace element selenium is incorporated as selenocysteine in all three deiodinases has decisively confirmed the clear-cut link between selenium and thyroid function. It has additionally been established that the thyroid […]

Read more »

Making the Case for RAI Treatment of Intra-thoracic Goiter

Approach to management of the patient with primary or secondary intrathoracic goiter. Hegedüs L , Bonnema SJ J Clin Endocrinol Metab. 2010 Dec;95(12):5155-62. Intrathoracic (substernal) goiter, depending on definition, is seen in up to 45% of all patients operated for goiter. It can either be primary (ectopic thyroid tissue detached from a cervical thyroid mass), […]

Read more »

Correlation of BRAF V600E mutations and tumor invaseness in papillary thyroid carcinoma

JCEM 2010, 95(9):4197-4205 Basolo et al Evaluation of the degree of neoplastic infiltration beyond the thyroid capsule remains a unique parameter that can be evaluated by histopathological examination to label a papillary thyroid carcinoma (PTC) of 20 mm or less in size as a pT1 or pT3 tumor. We correlated the BRAF V600E mutation with […]

Read more »

High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel

J Clin Endocrinol Metab. 2010 Sep;95(9):E54-7. Epub 2010 Jun 30. Troch M , Koperek O , Scheuba C , Dieckmann K , Hoffmann M , Niederle B , Raderer M Anaplastic thyroid carcinoma (ATC) is a rare but aggressive solid tumor with a very short survival time even with multimodality treatment. In view of in […]

Read more »